CNY 21.03
(2.59%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -80.13 Million | 271.62 Million | 171.06 Million | 70.51 Million | 171.62 Million | 96.03 Million |
Net Income | 8.33 Million | 67.34 Million | 108.39 Million | 188.83 Million | 183.23 Million | 99.55 Million |
Depreciation & Amortization | 17.84 Million | 13.12 Million | 11.22 Million | 9.51 Million | 8.43 Million | 7.89 Million |
Deferred income taxes | -59.91 Million | -10.98 Million | -13.92 Million | -3.54 Million | -10.55 Million | 10.8 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -393.54 Million | -122.61 Million | 232.98 Million | 169.03 Million | -64.21 Million | -27.15 Million |
Other non-cash items | 38.64 Million | 313.75 Million | -181.54 Million | -296.86 Million | 44.16 Million | 15.74 Million |
Investing Cash Flow | -32.97 Million | 54.18 Million | -24.25 Million | -257.24 Million | -49.81 Million | -62.27 Million |
Investments in PPE | -25.92 Million | -20.81 Million | -21.15 Million | -11.57 Million | -11.43 Million | -9.66 Million |
Acquisitions | 15.74 Million | - | 22.86 Million | -2.5 Million | 10.84 Million | 45.42 Million |
Investment purchases | -580 Million | -1 Billion | -560 Million | -837 Million | -905 Million | -99.75 Million |
Sales/Maturities of investments | 547.21 Million | 1.19 Billion | 484.03 Million | 695.95 Million | 2.76 Million | 1.71 Million |
Other Investing Activities | 10 Million | -116.73 Million | 50 Million | -102.12 Million | 853 Million | -54.32 Million |
Financing Cash Flow | -230.56 Million | -149.35 Million | -309.43 Million | 668.64 Million | -91.18 Million | -56.01 Million |
Debt repayment | -48.23 Million | -352.97 Million | -374.15 Million | -171.74 Million | -130.95 Million | -115.15 Million |
Dividends payments | -109.01 Million | -90.84 Million | -74.68 Million | -72.74 Million | -6.36 Million | -36.61 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -70.16 Million | 296.71 Million | 139.41 Million | 913.13 Million | 46.12 Million | 95.75 Million |
Accounts receivables | 100.01 Million | -158.55 Million | -267.52 Million | -431 Million | -510.05 Million | -192.96 Million |
Accounts payables | -445.27 Million | 41.44 Million | 522.89 Million | 235.05 Million | 531.59 Million | 297.21 Million |
Inventory | 11.63 Million | 5.49 Million | -8.45 Million | 368.52 Million | -75.19 Million | -142.21 Million |
Other working capital | 210.84 Million | -10.98 Million | -13.92 Million | -3.54 Million | -10.55 Million | 115.05 Million |
Cash at beginning of period | 574.19 Million | 397.74 Million | 560.37 Million | 78.44 Million | 47.82 Million | 70.07 Million |
Cash at end of period | 230.52 Million | 574.19 Million | 397.74 Million | 560.37 Million | 78.44 Million | 47.82 Million |
Capital Expenditure | -25.92 Million | -20.81 Million | -21.15 Million | -11.57 Million | -11.43 Million | -9.66 Million |
Effect of forex changes on cash | - | 1.21 | 0.67 | 1.12 | - | - |
Net cash flow / Change in cash | -343.67 Million | 176.45 Million | -162.62 Million | 481.92 Million | 30.62 Million | -22.25 Million |
Free Cash Flow | -106.06 Million | 250.81 Million | 149.9 Million | 58.94 Million | 160.19 Million | 86.36 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -63.28 Million | -38.14 Million | -7.42 Million | -31.76 Million | 8.33 Million | 2.55 Million |
Depreciation & Amortization | - | 4.63 Million | 4.63 Million | 17.84 Million | 17.84 Million | -8.55 Million |
Deferred income taxes | - | - | - | - | -59.91 Million | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | 322.49 Million | -393.54 Million | -242.47 Million |
Other non-cash items | 130.57 Million | 32.16 Million | -53.15 Million | -457.14 Million | 38.64 Million | 260.6 Million |
Investing Cash Flow | -45.32 Million | -96.6 Million | 41.53 Million | -71.96 Million | -32.97 Million | 179.54 Million |
Investments in PPE | -4.2 Million | -3.58 Million | -4.48 Million | -10.64 Million | -25.92 Million | -4.38 Million |
Acquisitions | -139.83 Million | 14.67 Million | 5.03 Million | 5.11 Million | 15.74 Million | 6.69 Million |
Investment purchases | -677.98 Million | -438 Million | - | - | -580 Million | -6.69 Million |
Sales/Maturities of investments | 756.7 Million | 330.3 Million | 40.98 Million | -6.44 Million | 547.21 Million | 107.24 Million |
Other Investing Activities | 20 Million | -423.32 Million | 46.01 Million | -60 Million | 10 Million | 76.69 Million |
Financing Cash Flow | -20.19 Million | -84.23 Million | 49.66 Million | 118.08 Million | -230.56 Million | -33.06 Thousand |
Debt repayment | -91.09 Million | - | - | -471.04 Thousand | -48.23 Million | - |
Dividends payments | - | -3.09 Million | -337.14 Thousand | -1.42 Million | -109.01 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 70.89 Million | -53.09 Million | 50 Million | 119.98 Million | -70.16 Million | -33.06 Thousand |
Accounts receivables | - | - | - | 100.01 Million | 100.01 Million | -145.74 Million |
Accounts payables | - | - | - | - | -445.27 Million | -848.56 Thousand |
Inventory | - | - | - | 11.63 Million | 11.63 Million | -96.73 Million |
Other working capital | - | - | - | 210.84 Million | 210.84 Million | 848.56 Thousand |
Cash at beginning of period | 617.33 Million | 801.86 Million | 230.52 Million | 332.97 Million | 574.19 Million | 148.58 Million |
Cash at end of period | 537.34 Million | 617.33 Million | 261.14 Million | 230.52 Million | 230.52 Million | 332.97 Million |
Capital Expenditure | -4.2 Million | -3.58 Million | -4.48 Million | -10.64 Million | -25.92 Million | -4.38 Million |
Effect of forex changes on cash | - | - | - | - | - | -7.23 Million |
Net cash flow / Change in cash | -79.98 Million | -184.53 Million | 30.61 Million | -102.45 Million | -343.67 Million | 184.39 Million |
Free Cash Flow | 63.08 Million | -14.21 Million | -65.06 Million | -159.21 Million | -106.06 Million | 7.73 Million |
4848
BIOGEN
PARKERAC
2119
CGLO
STEP2COR